Updated clinical trial data indicate that the First Line Obstructive Sleep Apnea Treatment study (FLOSAT)—an ongoing head-to-head study comparing the effectiveness of precision oral appliance therapy (OAT) as first-line treatment versus CPAP therapy—is on track to achieve all endpoints, according to ProSomnus Inc. The data was presented at the ProSleep 2023 Users Conference earlier this…
The Therapy for Black Girls Podcast is a weekly conversation with Dr. Joy Harden Bradford, a licensed Psychologist in Atlanta, Georgia, about all things mental health, personal development, and all the small decisions we can make to become the best possible versions of ourselves. I’ve been wanting to experiment with sharing some quicker, more actionable…
The little years of parenting are a wonderful and sometimes unbearable wilderness. Nighttime can be a series of uncivil wars — getting children fed and bathed (and sometimes re-bathed), then getting them into the right bed, at the right time, with the right bedtime story or song (only after finding that beloved stuffie), then keeping…
Incannex Healthcare Ltd, a clinical-stage pharmaceutical company developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies, has received approval from the US Food and Drug Administration (FDA) for an Investigational New Drug (IND) opening pivotal IHL-42X phase 2/3 clinical trial for obstructive sleep apnea in the United States as planned. Incannex submitted the IND application…